Home > Healthcare > Pharmaceuticals > Drug Delivery > Softgel Capsules Market

Softgel Capsules Market Size

  • Report ID: GMI5272
  • Published Date: Jun 2023
  • Report Format: PDF

Softgel Capsules Market Size

Softgel Capsules Market size was worth over USD 8.9 billion in 2022. Driven by the rising prevalence of chronic disorders globally.

 

Chronic ailments such as cardiovascular diseases, cancer, and others have gained significant prominence. As per CDC, stroke is diagnosed in around 795,000 people every year in the U.S. alone, of which nearly 610,000 are new stroke cases. The rising disease burden and the subsequent surge in demand for advanced drug therapies will propel the demand for softgel capsules. Moreover, the growing number of ongoing clinical trials and novel product innovations will create ample growth opportunities for softgel capsules business.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of softgel capsules was worth more than USD 8.9 billion in 2022and will grow at 5.5% CAGR from 2023 to 2032, attributed to the growing occurrence of chronic disorders globally.

Gelatin-based softgel capsules market was valued at over USD 8 billion in 2022, owing to their superior pH-dependent gelling and thermo-reversibility properties.

North America market size for softgel capsules will reach more than USD 3.9 billion by 2032, attributed to the surging healthcare spending in the region.

Major softgel capsules industry players include Procaps Group, Fuji Capsules Co. Ltd., Estrellus, Delpharm Evreux, Captek Softgel International Inc., Patheon, and Guangdong Yichao Biological Co. Ltd., among others.

Softgel Capsules Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 13
  • Tables & Figures: 327
  • Countries covered: 21
  • Pages: 200
 Download Free Sample